MYCN amplification and consequent overexpression has been also found in other cancers of neural origin, including glioblastoma, medulloblastoma, retinoblastoma, small cell lung carcinoma, peripheral neuroectodermal tumors [28]. This evidence concerns the gene MYCN and retinoblastoma.